N V Perricone M D Latin America LLC is categorized under Doctors in Meriden, CT and active since 2003.
N V Perricone M D Latin America LLC was established in 2003, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Nicholas V Perricone at the company’s single location by writing to 639 Research Parkway, Meriden, Connecticut CT 06450 or by phoning (203) 379-0726. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | N V Perricone M D Latin America LLC |
| Contact Person: | Nicholas V Perricone |
| Address: | 639 Research Parkway, Meriden, Connecticut 06450 |
| Phone Number: | (203) 379-0726 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
N V Perricone M D Latin America LLC was started in 2003 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Nicholas V Perricone for inquiries that concern N V Perricone M D Latin America LLC by calling the company number (203) 379-0726, as your correspondence is most welcome. Additionally, the physical location of the single location of N V Perricone M D Latin America LLC can be found at the coordinates 41.507995,-72.767292 as well as the street address 639 Research Parkway in Meriden, Connecticut 06450.
For its online presence, you may visit N V Perricone M D Latin America LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.